Related Experiment Videos
Considerations on current and future trials in hypertension
1Cattedra di Medicina Interna and Centro di Fisiologia Clinica e Ipertensione, Ospedale S. Gerardo, Monza, Italy.
Insights
Hypertension increases cardiovascular disease risk. Antihypertensive treatment lowers this risk, but some questions remain. The Insight Study investigates benefits in hypertensive patients with other cardiovascular risk factors.
Area of Science:
- Cardiology
- Epidemiology
- Clinical Trials
Background:
- Hypertension is a significant risk factor for cardiovascular disease (CVD).
- Antihypertensive treatment effectively reduces elevated blood pressure and associated CVD risk.
- Despite established benefits, specific questions regarding antihypertensive treatment efficacy persist.
Purpose of the Study:
- To review existing clinical trial data on antihypertensive treatment.
- To critically examine unanswered questions in antihypertensive therapy.
- To highlight ongoing trials, including the Insight Study, addressing these gaps, particularly in patients with additional cardiovascular risk factors.
Main Methods:
- Review of published clinical trials on antihypertensive treatment.
- Critical analysis of existing literature to identify knowledge gaps.
- Focus on the design and objectives of the Insight Study.
Main Results:
- Evidence confirms blood pressure reduction lowers cardiovascular risk.
- Several questions regarding the optimal use and specific benefits of antihypertensive treatments remain.
- The Insight Study is designed to provide further clarity on treatment benefits in a specific patient population.
Conclusions:
- Antihypertensive treatment is crucial for managing hypertension and reducing cardiovascular risk.
- Further research is needed to fully elucidate the benefits of antihypertensive treatment in diverse patient groups.
- The Insight Study aims to contribute valuable data to this ongoing scientific inquiry.
Abstract:
Conclusive evidence from large-scale epidemiological studies has shown that hypertension is a major risk factor for cardiovascular disease. Large-scale intervention trials have indicated that, by reducing elevated blood pressure values with antihypertensive treatment, the risk can be decreased. Despite the large body of evidence on the protective effects of the blood pressure reduction, several questions concerning the benefit of antihypertensive treatment remain unanswered. This paper briefly reviews the information provided by clinical trials on antihypertensive treatment. It also critically examines the questions that have remained partially or totally unanswered and the trials that are currently addressing them. Focus is directed on the Insight Study which addresses the benefit of antihypertensive treatment in hypertensive subjects with additional cardiovascular risk factors.